PyInvesting

Market research

DGX Quest Diagnostics Incorporated

NYSE USD Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
27B
P/E ratio
25.97
Analyst target
245.8667
Dividend yield
1.4%
Beta
0.55

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

Quest Diagnostics Incorporated is currently in a long term uptrend where the price is trading 6.7% above its 200 day moving average.

From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.9.

Quest Diagnostics Incorporated's total revenue rose by 55.9% to $3B since the same quarter in the previous year.

Its net income has increased by 128.9% to $579M since the same quarter in the previous year.

Finally, its free cash flow grew by 115.3% to $379M since the same quarter in the previous year.

Based on the above factors, Quest Diagnostics Incorporated gets an overall score of 5/5.